Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 3Unknown 2Withdrawn 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Solid Tumor 1Small Cell Lung Carcinoma 1Primary Condition: Advanced Tumors 1Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

vistusertib 2toripalimab 1tislelizumab 1tanespimycin 1sargramostim 1roniciclib 1abemaciclib 1Letrozole 1Ipilimumab 1Hydroxychloroquine 1Fulvestrant 1Anastrozole 1Albumin-Bound Paclitaxel 1AMG 337 14-toluenesulfonamide 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Solid Tumor × toripalimab × Clear all
NCT05165849 2022-05-20

A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors

Genfleet Therapeutics (Shanghai) Inc.

Phase 1/2 Withdrawn
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡